The methylation of MGMT promoter is linked to a favorable prognosis in glioma treated by TMZ since MGMT expression is decreased, which leads to impaired DNA repair ability in tumor cells and enhances the sensitivity to alkylating agents [10]. Here, MGMT is linked to neoplasm.